0001209191-23-045664.txt : 20230814
0001209191-23-045664.hdr.sgml : 20230814
20230814165918
ACCESSION NUMBER: 0001209191-23-045664
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230811
FILED AS OF DATE: 20230814
DATE AS OF CHANGE: 20230814
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: REEVE GRAHAM D.
CENTRAL INDEX KEY: 0001519948
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11151
FILM NUMBER: 231171668
MAIL ADDRESS:
STREET 1: 1300 W. SAM HOUSTON PARKWAY
STREET 2: SUITE 300
CITY: HOUSTON
STATE: TX
ZIP: 77042
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: U S PHYSICAL THERAPY INC /NV
CENTRAL INDEX KEY: 0000885978
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000]
IRS NUMBER: 760364866
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1300 WEST SAM HOUSTON PARKWAY
STREET 2: SUITE 300
CITY: HOUSTON
STATE: TX
ZIP: 77043
BUSINESS PHONE: 7132977000
MAIL ADDRESS:
STREET 1: 1300 WEST SAM HOUSTON PARKWAY
STREET 2: SUITE 300
CITY: HOUSTON
STATE: TX
ZIP: 77043
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-08-11
0
0000885978
U S PHYSICAL THERAPY INC /NV
USPH
0001519948
REEVE GRAHAM D.
1300 W SAM HOUSTON PKWY S
SUITE 300
HOUSTON
TX
77042
0
1
0
0
COO
0
Common Stock
13614
D
Common Stock
2023-08-11
4
S
0
4114
109.99
D
7577
I
Reeve Trust
Includes 13,614 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,724 shares on October 1, 2023; 1,730 shares on January 1, 2024; 1,286 shares on each of April 1, 2024, July 1, 2024, October 1, 2024 and January 1, 2025; 936 shares on each of April 1, 2025 July 1, 2025 and October 1, 2025; 952 shares on January 1, 2026; and 312 shares on each of April 1, 2026, July 1, 2026 and October 1, 2026; and the final 320 shares on January 1, 2027, if he is an employee of the Company on those dates.
The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $109.27 to $111.14, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
/s/ Graham D Reeve
2023-08-14